Cupid Q1 FY27 Results (NSE: CUPID)
Signal: Margin expansion
The read
The key inflection is the fifth consecutive quarter of YoY OPM expansion: consolidated EBITDA margin reached 40.3% from 28.0% YoY, while revenue accelerated to ₹15,471.50 lakh (+158.7% YoY); however, the 1522bps gross-margin tailwind is not attributed by management and needs confirmation before being treated as structural.
| Metric | Value | YoY | QoQ |
|---|---|---|---|
| Revenue | ₹154.72 Cr | +158.7% | +29.0% |
| EBIT | ₹0.61 Cr | N/A | |
| Net profit | ₹44.15 Cr | +194.2% | |
| EPS | ₹0.33 | +200.0% | |
| EBIT margin | 40.3% |
P&L walk
Consolidated revenue increased to ₹15,471.50 lakh (+158.7% YoY, +29.0% QoQ), while the raw-material ratio fell to 12.1% from 27.3% YoY and EBITDA margin expanded to 40.3% from 28.0%, driving PAT to ₹4,414.88 lakh (+194.2% YoY).
Key positives
- Revenue reached ₹15,471.50 lakh, up 158.7% YoY and 29.0% QoQ, accelerating from Q4FY26 growth of 114.3% YoY.
- EBITDA margin expanded to 40.3%, up 1230bps YoY and 930bps QoQ, extending the fifth consecutive quarter of YoY margin expansion.
- Raw material cost fell to 12.1% of revenue from 27.3% YoY, supporting a 1522bps gross-margin expansion.
- PAT rose to ₹4,414.88 lakh, up 194.2% YoY, while other income declined 54.2% YoY, indicating that earnings growth was primarily operating-led.
- Standalone PAT of ₹4,416.21 lakh was only ₹1.33 lakh above consolidated PAT of ₹4,414.88 lakh, showing negligible subsidiary drag or uplift.
Key concerns
- The 1522bps gross-margin expansion is material but the filing does not disclose whether it came from input deflation, pricing power or product mix, leaving durability unproven.
- Purchase of stock-in-trade rose 552.0% YoY to ₹5,461.99 lakh, materially faster than revenue growth and potentially increasing the importance of trading mix and inventory conversion.
- The company is exploring a new West Bengal project covering medical devices and healthcare products, which could broaden the business beyond personal care before feasibility, approvals and definitive arrangements are finalized.
- Fair value loss of ₹4,245.62 lakh on an equity instrument was recorded in OCI, creating substantial reported comprehensive-income volatility even though it did not reduce PAT.
Research and educational content only. Not investment advice.